Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Biocon Limited    BIOCON   INE376G01013

BIOCON LIMITED

(BIOCON)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
395.65(c) 398(c) 402.7(c) 399.75(c) 394.6(c) Last
2 691 673 2 769 928 2 975 783 1 939 204 1 607 741 Volume
+1.40% +0.59% +1.18% -0.73% -1.29% Change
More quotes
Financials
Sales 2021 73 680 M 1 007 M 1 007 M
Net income 2021 7 298 M 99,8 M 99,8 M
Net Debt 2021 25 716 M 352 M 352 M
P/E ratio 2021 65,3x
Yield 2021 0,28%
Sales 2022 90 511 M 1 237 M 1 237 M
Net income 2022 11 400 M 156 M 156 M
Net Debt 2022 19 576 M 268 M 268 M
P/E ratio 2022 40,7x
Yield 2022 0,36%
Capitalization 468 B 6 383 M 6 394 M
EV / Sales 2021 6,70x
EV / Sales 2022 5,38x
Nbr of Employees 12 609
Free-Float 33,5%
More Financials
Company
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and... 
More about the company
Notations Surperformance© of Biocon Limited
Trading Rating : Investor Rating :
More Ratings
All news about BIOCON LIMITED
03/02BIOCONá : Arm Appoints New Chief Commercial Officer for Emerging Markets
MT
03/01BIOCONá : Appoints New Deputy CEO for Biocon Biologics Unit
MT
02/28BIOCONá : Arm Secures Nod from European Panel for Abevmy Drug
MT
02/23Indian pharma firms go local seeking to end reliance on China
RE
01/28FACTBOX : What Indian industries want from the Modi government's Feb. 1 budget
RE
01/24BIOCONá : Logs Lower Fiscal Q3 Consolidated Net Profit
MT
01/22Sensex, Nifty end lower as banks, metals drag; Reliance results in focus
RE
01/22Indian shares end lower as banks, metals drag; Reliance results in focus
RE
01/22Indian shares flat; Reliance in focus ahead of results
RE
01/18BIOCON LIMITEDá : quaterly earnings release
01/08Indian IT stocks drive Nifty index to record high ahead of TCS results
RE
01/07BIOCONá : Arm Gets $75 Million Equity Investment from Abu Dhabi-Based ADQ
MT
2020EXCLUSIVE : Drugmakers to hike prices for 2021 as pandemic, political pressure p..
RE
2020Drugmakers to hike prices for 2021 as pandemic, political pressure put revenu..
RE
2020BIOCONá : Launches Tacrolimus Capsules in US
MT
More news
News in other languages on BIOCON LIMITED
02/23Farmacéuticas indias se vuelven locales para terminar con dependencia de Chin..
01/18BIOCON LIMITEDá : Veröffentlichung des Quartalsergebnisses
01/18BIOCON LIMITEDá : publication des résultats trimestriels
2020Novartis obtient une décision favorable d'un tribunal US sur Gilenya
2020Novartis begrüsst Entscheidung von US-Gericht zu Gilenya (fingolimod)
More news
Chart BIOCON LIMITED
Duration : Period :
Biocon Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOCON LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 407,95 INR
Last Close Price 394,60 INR
Spread / Highest target 26,7%
Spread / Average Target 3,38%
Spread / Lowest Target -39,2%
EPS Revisions
Managers and Directors
NameTitle
Siddharth Mittal Chief Executive Officer, Director & MD
Anupam Jindal Chief Financial Officer
Kiran Mazumdar-Shaw Executive Chairman
Manoj Kumar Pananchukunnath Head-Regulatory Sciences, Research & Development
Sandeep Nilkanth Athalye Head-Clinical Development & Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
BIOCON LIMITED-14.11%6 383
GILEAD SCIENCES, INC.7.71%81 201
VERTEX PHARMACEUTICALS-12.08%55 106
WUXI APPTEC CO., LTD.0.64%50 791
REGENERON PHARMACEUTICALS-7.53%48 070
BEIGENE, LTD.11.93%27 598